Ann: Letter to Shareholders & Notice of Annual General Meeting, page-429

Well if for no other reason than it passed all of the necessary requirements for Imec to consider it worthy of the effort under their mandate, as stated by GSK and the VP.

And it is my humble opinion that your facts Sir are somewhat baseless unless you wish to quote from whence they were sourced.

Of course the retention & endurance figures will be great to see so be a good fellow and grab then for us can you please..

Cause last time I checked a filamentry wear mechanism will indeed fail over time, where as non filamentary isn’t quite as prone to the same degradation.

Thanks in advance, 8tey